Fecal microbiota transplantation in treating Clostridium difficile infection.
Clostridium difficile infection (CDI) is an increasingly common and severe international health problem. Customary treatment of this infection, usually with antibiotics, is often ineffective and its recurrence is common. In recent years the treatment of recurrent or refractory CDI by the transfer of stool from an uninfected person, so called fecal "microbiota transplantation" has become recognized as effective and generally safe. The effectiveness of this novel treatment is incompletely defined but is likely to be due to its correction of the intestinal dysbiosis that characterizes the disease. Practical methods for the administration of the transplantation have been described. This review summarizes the current reported experiences with fecal microbiota transplantation in the treatment for CDI.
Division of Gastroenterology and Hepatology, University of Colorado School of Medicine, Aurora, CO, USA.
William R
WR
Brown
D016360:Clostridioides difficile; D004761:Enterocolitis, Pseudomembranous / Q000382:microbiology / Q000628:therapy*; D005243:Feces / Q000382:microbiology*; D006801:Humans; D064307:Microbiota; D010342:Patient Acceptance of Health Care; D016378:Tissue Transplantation / Q000009:adverse effects / Q000379:methods* / Q000639:trends
Clostridium difficile; dysbiosis; fecal enema; fecal microbiota transplantation; pseudomembranous enterocolitis